Table 2.
Association of the D-repeat of ASPN in patients with DDH in a Han Chinese population
| Groups compared | D14 vs. Others | D13 vs. Others | D14 vs. D13 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | P-value | 95% CI | OR | P-value | 95% CI | OR | P-value | 95% CI | |
| All patients (n = 370) vs. All controls (n = 445) |
1.83 | 0.0016 | 1.25 to 2.68 | 0.67 | 1.3*10-4 | 0.55 to 0.82 | 2.03 | 2.7*10-4 | 1.38 to 2.99 |
| Female patients (n = 313) vs. Female controls (n = 290) |
1.95 | 0.0025 | 1.26 to 3.03 | 0.71 | 0.004 | 0.56 to 0.90 | 2.10 | 9.3*10-4 | 1.34 to 3.29 |
| Male patients (n = 57) vs. Male controls (n = 155) |
1.02 | 0.96 | 0.39 to 2.68 | 0.51 | 0.002 | 0.33 to 0.79 | 1.34 | 0.55 | 0.50 to 3.59 |
ASPN, asporin; CI, confidence interval; D-repeat, aspartic acid repeat; DDH, developmental dysplasia of the hip; OR, odds ratio.